Conversation with Steve Miller of Express Scripts (Part 1)

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

Has the Time Come for a US NICE?
The ABC’s (and D’s) of Changing Medicare Drug Policy
Medicare’s CAR (-T) Wreck
Getting to Precision Medicine for I-O Combinations – It’s Even More Complicated